QuadraMed scores four new EHR clients

Jeff Byers | | Health Imaging | Practice Management
Healthcare technology developer QuadraMed has announced that three health systems in the U.S., and one Toronto-based healthcare organization have licensed its EHR product, QuadraMed CPR (QCPR).

QCPR is an enterprise-wide computerized patient record and EHR system that includes closed-loop medication management, computerized physician order entry, clinical decision support, as well as integrated laboratory and radiology management systems, said QuadraMed.

The new QCPR clients include: Hunterdon Medical Center in Flemington, N.J.; Galion Hospital in Galion, Ohio; Summa Health System-Barberton Hospital in Barberton, Ohio; and the Toronto Rehabilitation Institute in Toronto.



Jeff Byers

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.